Hydroxyurea Suppliers & Bulk Manufacturers
Available Forms: Capsules and Tablets
Available Strengths: Capsules: 200 mg, 300 mg, 400 mg, 500 mg; Tablets: 100 mg, 500 mg, 1,000 mg
Reference Brands: Hydrea, Droxia , Siklos
Category: Anemia
Hydroxyurea is an oral cytoreductive drug used for sickle cell disease, CML, and polycythemia vera. Available in 100–500 mg strengths under brands like Hydrea, Droxia, and Siklos. Ideal for pharma B2B sourcing and global bulk supply.
Product Description:
Hydroxyurea is a widely used oral chemotherapeutic and hematologic drug indicated for sickle cell disease, chronic myeloid leukemia (CML), polycythemia vera, and essential thrombocythemia. It works by inhibiting DNA synthesis and increasing fetal hemoglobin (HbF) in sickle cell patients. Marketed under brands like Hydrea, Droxia, and Siklos, it is available in 100 mg to 500 mg capsules and tablets. Manufactured under GMP standards, Hydroxyurea is ideal for pharmaceutical distributors, hospitals, and global B2B buyers. We offer competitive pricing, regulatory documentation, and reliable bulk supply. Contact us today for high-quality Hydroxyurea sourcing and international export support.
Hydroxyurea — third party manufacturing & bulk supply
Hydroxyurea is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Hydroxyurea listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Hydroxyurea →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Hydroxyurea is used to treat sickle cell disease by increasing fetal haemoglobin levels and reducing painful crises. It is also used in certain cancers such as chronic myeloid leukaemia and in conditions like polycythaemia vera to reduce high blood cell counts.
It is made from a synthetic hydroxylated urea compound that works by inhibiting DNA synthesis in rapidly dividing cells and increasing fetal haemoglobin production.
Common trade names include Hydrea, Droxia, and Siklos.
It is manufactured by several companies globally, including Bristol Myers Squibb and various approved generic manufacturers.
The generic name is Hydroxyurea.
Brand names include Hydrea, Droxia, and Siklos.
It is manufactured in multiple countries by both innovator and generic pharmaceutical companies.
Related Products
Mitapivat Sulfate
Strength:
5 mg, 20 mg, 50 mg
Form: Tablets
Reference Brands: Pyrukynd (USA)
View Details
Eltrombopag Cholin 50 Mg Tablet
Strength:
12.5 mg, 25 mg, 50 mg, and 75 mg
Form: Tablets / Oral suspension
Reference Brands: Promacta (USA), Revolade (EU)
View Details
Epoetin Alfa
Strength:
1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
